Skip to main content
. Author manuscript; available in PMC: 2017 May 13.
Published in final edited form as: J Thorac Cardiovasc Surg. 2015 Sep 28;151(2):376–382. doi: 10.1016/j.jtcvs.2015.08.079

Table 2.

Transfusion at Specified Time Points.

N=22 During CPB After CPB* ICU arrival thru POD2
Cell Saver (mL), Median (IQR) 178 (18–303) 505 (242–725) -
PRBC
 Number of Patients Transfused (%) 2 (9.1%) 9 (40.9%) 6 (27.3%)
 Median (IQR) Units Among Patients Transfused 1.5 (1, 2) 1 (1, 2) 1 (1, 2)
FFP
 Number of Patients Transfused (%) 17 (77.3%) 7 (31.8%) 1 (4.5%)
 Median (IQR) Units Among Patients Transfused 4 (4, 4) 2 (1, 4) 5
Platelets
 Number of Patients Transfused (%) 4 (18.2%) 20 (90.9%) 1 (4.5%)
 Median (IQR) Units Among Patients Transfused 1.5 (1, 2) 2 (1, 2) 1
Cryoprecipitate
 Number of Patients Transfused (%) 0 3 (13.6%) 0
 Median (IQR) Units Among Patients Transfused NA 1 (1, 2) NA

CPB=cardiopulmonary bypass; SD=standard deviation; IQR=interquartile range; ICU=intensive care unit; POD=post-operative day.

*

After CPB includes before, during, and after administration of HFC until the end of surgery.